Met Life Investment Management, LLC Kura Oncology, Inc. Transaction History

Met Life Investment Management, LLC

$18 Billion
Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 44,828 shares of KURA stock, worth $365,348. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,828

Previous 42,052 6.6%

Holding current value

$365,348

Previous $821,000 52.5%

% of portfolio

0.0%

Previous 0.0%

45 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$8.51 - $19.21 $23,623 - $53,326	2,776 Added 6.6%	44,828 $390,000
Q2 2024 Aug 13, 2024	BUY	$17.53 - $22.98 $82,741 - $108,465	4,720 Added 12.64%	42,052 $865,000
Q1 2024 May 14, 2024	BUY	$13.42 - $23.53 $500,995 - $878,421	37,332 New	37,332 $796,000
Q3 2023 May 09, 2024	BUY	$8.44 - $11.86 $12,119 - $17,030	1,436 Added 4.0%	37,332 $340,000
Q3 2023 Apr 29, 2024	BUY	$8.44 - $11.86 $12,119 - $17,030	1,436 Added 4.0%	37,332 $340,000
Q3 2023 Nov 14, 2023	BUY	$8.44 - $11.86 $12,119 - $17,030	1,436 Added 4.0%	37,332 $340,000
Q2 2023 Apr 29, 2024	BUY	$9.62 - $13.99 $345,319 - $502,185	35,896 New	35,896 $379,000
Q1 2023 May 09, 2024	BUY	$10.71 - $14.6 $384,446 - $524,081	35,896 New	35,896 $439 Million
Q4 2022 May 10, 2024	BUY	$11.23 - $16.9 $10,623 - $15,987	946 Added 2.71%	35,896 $445,000
Q4 2022 Mar 22, 2023	BUY	$11.23 - $16.9 $10,623 - $15,987	946 Added 2.71%	35,896 $445,000
Q4 2022 Feb 15, 2023	BUY	$11.23 - $16.9 $10,623 - $15,987	946 Added 2.71%	35,896 $445,000
Q3 2022 Jun 14, 2023	SELL	$12.01 - $19.45 $11,361 - $18,399	-946 Reduced 2.64%	34,950 $477,000
Q2 2022 Jun 20, 2023	SELL	$10.71 - $18.33 $10,131 - $17,340	-946 Reduced 2.64%	34,950 $640,000
Q1 2022 May 10, 2024	BUY	$11.78 - $16.98 $411,711 - $593,451	34,950 New	34,950 $561,000
Q1 2022 Jun 20, 2023	SELL	$11.78 - $16.98 $11,143 - $16,063	-946 Reduced 2.64%	34,950 $561,000
Q1 2022 Mar 22, 2023	BUY	$11.78 - $16.98 $132,254 - $190,634	11,227 Added 47.33%	34,950 $561,000
Q1 2022 May 12, 2022	BUY	$11.78 - $16.98 $132,254 - $190,634	11,227 Added 47.33%	34,950 $562,000
Q4 2021 Jun 21, 2023	SELL	$12.22 - $19.57 $148,754 - $238,225	-12,173 Reduced 33.91%	23,723 $332,000
Q3 2021 Jun 21, 2023	SELL	$15.42 - $21.72 $187,707 - $264,397	-12,173 Reduced 33.91%	23,723 $444,000
Q2 2021 Jun 21, 2023	SELL	$20.85 - $29.88 $253,807 - $363,729	-12,173 Reduced 33.91%	23,723 $494,000
Q1 2021 May 17, 2024	SELL	$24.75 - $39.14 $336,822 - $532,656	-13,609 Reduced 36.45%	23,723 $670,000
Q1 2021 Jun 26, 2023	SELL	$24.75 - $39.14 $301,281 - $476,451	-12,173 Reduced 33.91%	23,723 $671 Million
Q1 2021 Mar 22, 2023	SELL	$24.75 - $39.14 $87,021 - $137,616	-3,516 Reduced 12.91%	23,723 $670,000
Q1 2021 May 14, 2021	SELL	$24.75 - $39.14 $87,021 - $137,616	-3,516 Reduced 12.91%	23,723 $671,000
Q4 2020 May 24, 2024	BUY	$29.0 - $41.62 $90,799 - $130,312	3,131 Added 12.99%	27,239 $889,000
Q4 2020 Jun 22, 2023	SELL	$29.0 - $41.62 $251,053 - $360,304	-8,657 Reduced 24.12%	27,239 $889,000
Q4 2020 Mar 22, 2023	BUY	$29.0 - $41.62 $90,799 - $130,312	3,131 Added 12.99%	27,239 $889,000
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $90,799 - $130,312	3,131 Added 12.99%	27,239 $890,000
Q3 2020 Jun 26, 2023	SELL	$16.3 - $30.64 $192,144 - $361,184	-11,788 Reduced 32.84%	24,108 $738,000
Q2 2020 May 24, 2024	SELL	$7.95 - $18.81 $105,130 - $248,743	-13,224 Reduced 35.42%	24,108 $393 Million
Q2 2020 Jun 26, 2023	SELL	$7.95 - $18.81 $93,714 - $221,732	-11,788 Reduced 32.84%	24,108 $392,000
Q2 2020 Mar 22, 2023	BUY	$7.95 - $18.81 $83,125 - $196,677	10,456 Added 76.59%	24,108 $392,000
Q2 2020 Aug 14, 2020	BUY	$7.95 - $18.81 $83,125 - $196,677	10,456 Added 76.59%	24,108 $393,000
Q1 2020 Jul 12, 2023	SELL	$6.45 - $14.04 $143,473 - $312,305	-22,244 Reduced 61.97%	13,652 $135,000
Q4 2019 Jul 12, 2023	SELL	$12.97 - $15.94 $288,504 - $354,569	-22,244 Reduced 61.97%	13,652 $187,000
Q3 2019 Jul 12, 2023	SELL	$14.75 - $20.87 $328,099 - $464,232	-22,244 Reduced 61.97%	13,652 $207,000
Q2 2019 Jul 12, 2023	SELL	$14.71 - $19.79 $327,209 - $440,208	-22,244 Reduced 61.97%	13,652 $268,000
Q1 2019 Jul 13, 2023	SELL	$13.73 - $16.87 $305,410 - $375,256	-22,244 Reduced 61.97%	13,652 $226,000
Q4 2018 Jul 13, 2023	SELL	$10.6 - $17.49 $235,786 - $389,047	-22,244 Reduced 61.97%	13,652 $191,000
Q4 2018 Mar 22, 2023	SELL	$10.6 - $17.49 $81,863 - $135,075	-7,723 Reduced 36.13%	13,652 $191,000
Q4 2018 Feb 14, 2019	SELL	$10.6 - $17.49 $81,863 - $135,075	-7,723 Reduced 36.13%	13,652 $192,000
Q3 2018 Jul 13, 2023	SELL	$16.65 - $21.85 $370,362 - $486,031	-22,244 Reduced 61.97%	13,652 $238,000
Q3 2018 Mar 22, 2023	SELL	$16.65 - $21.85 $241,774 - $317,283	-14,521 Reduced 40.45%	21,375 $374,000
Q3 2018 Nov 14, 2018	BUY	$16.65 - $21.85 $187,695 - $246,315	11,273 Added 111.59%	21,375 $374,000
Q4 2017 Feb 15, 2018	BUY	$13.5 - $16.65 $136,377 - $168,198	10,102	10,102 $155,000

Others Institutions Holding KURA

# of Institutions

193

Shares Held

77.5M

Call Options Held

103K

Put Options Held

106K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $545M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Kura Oncology, Inc. Transaction History